Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation

Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation

Yanqiu Wu,1,2 Jiangyue Qin,1,2 Junyun He,3 Yongchun Shen,1,2 Hao Wang,1,2 Yanping Li,4 Qianglin Zeng,5 Jiajia Dong,1,2 Yunfei An,6 Shuguang Xiong,7 Mei Feng,2 Fuqiang Wen1,2 1Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, West China Hospital of Sichuan University, Cheng...

Full description

Bibliographic Details
Main Authors: Wu Y, Qin J, He J, Shen Y, Wang H, Li Y, Zeng Q, Dong J, An Y, Xiong S, Feng M, Wen F
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:International Journal of COPD
Subjects:
chronic obstructive pulmonary disease
endostatin
lung function
angiogenesis
inflammation
Online Access:https://www.dovepress.com/serum-endostatin-is-a-novel-marker-for-copd-associated-with-lower-lung-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/serum-endostatin-is-a-novel-marker-for-copd-associated-with-lower-lung-peer-reviewed-article-COPD

Similar Items